## Consolidated Statement of Equity

**Year Ended**

|  | Sep 26, 2020 |
| --- | --- |
| **      Increase (Decrease) in Stockholders' Equity [Roll Forward]** |  |
|         Total Stockholders' Equity - Beginning balance | 90,488 |
| *          Common stock and additional paid-in capital* | 50,779 |
| *          Retained earnings* | 14,966 |
| *          Accumulated other comprehensive income/(loss)* | (406) |
| *          Cumulative Foreign Currency Translation* | (1,375) |
| *          Unrealized Gains/Losses on Derivative Instruments* | (877) |
| *          Unrealized Gains/Losses on Marketable Debt Securities* | 1,846 |
| *          Cumulative Effect, Period of Adoption, Adjustment - Retained earnings* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accumulated other comprehensive income/(loss)* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accounting Standards Update 2017-12 - Retained earnings* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accounting Standards Update 2017-12 - Accumulated other comprehensive income/(loss)* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Cumulative Foreign Currency Translation* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Unrealized Gains/Losses on Derivative Instruments* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Unrealized Gains/Losses on Marketable Debt Securities* |  |
|         Common stock issued - Beginning balance |  |
| *          Common stock and additional paid-in capital - Ending balance* | 880 |
|         Common stock withheld related to net share settlement of equity awards - Beginning balance |  |
| *          Common stock and additional paid-in capital* | 2,250 |
| *          Retained earnings - Ending balance* | 1,604 |
|         Share-based compensation - Beginning balance |  |
| *          Common stock and additional paid-in capital - Ending balance* | 6,975 |
|         Net Income - Beginning balance | 57,411 |
| *          Retained earnings - Ending balance* | 57,411 |
|         Dividends and dividend equivalents declared - Beginning balance |  |
| *          Retained earnings - Ending balance* | 14,087 |
|         Common stock repurchased - Beginning balance | 72,500 |
| *          Retained earnings - Ending balance* | 72,516 |
|         Other comprehensive income/(loss) - Beginning balance | 42 |
| *          Accumulated other comprehensive income/(loss)* | 42 |
| *          Cumulative Foreign Currency Translation* | 88 |
| *          Unrealized Gains/Losses on Derivative Instruments* | (1,185) |
| *          Unrealized Gains/Losses on Marketable Debt Securities - Ending balance* | 1,139 |
|         Total Stockholders' Equity | 65,339 |
| *          Common stock and additional paid-in capital* | 50,779 |
| *          Retained earnings* | 14,966 |
| *          Accumulated other comprehensive income/(loss)* | (406) |
| *          Cumulative Foreign Currency Translation* | (1,375) |
| *          Unrealized Gains/Losses on Derivative Instruments* | (877) |
| *          Unrealized Gains/Losses on Marketable Debt Securities* | 1,846 |
| *          Cumulative Effect, Period of Adoption, Adjustment - Retained earnings* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accumulated other comprehensive income/(loss)* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accounting Standards Update 2017-12 - Retained earnings* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Accounting Standards Update 2017-12 - Accumulated other comprehensive income/(loss)* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Cumulative Foreign Currency Translation* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Unrealized Gains/Losses on Derivative Instruments* |  |
| *          Cumulative Effect, Period of Adoption, Adjustment - Unrealized Gains/Losses on Marketable Debt Securities - Ending balance* |  |
|       Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) | 0.795 |